Objective: To identify outcomes in hearing loss (HL) diagnosis and intervention in infants with a failed newborn hearing screen (NBHS) and otitis media with effusion (OME) compared to those with failed NBHS and without OME.
Study Design: Retrospective review.
Setting: Tertiary medical center.
Methods: A chart review was performed on infants referred to Primary Children's Hospital for failed NBHS from 2012 to 2018. Eighty infants with failed NBHS and OME and 55 with failed NBHS and no OME were included. Incidence of permanent HL along with the age of HL confirmation and early intervention (EI) enrollment were compared.
Results: The incidence of OME in infants with failed NBHS was 59.3%. Fifty-six percent of infants with OME and 12.5% of those without OME did not receive definitive hearing confirmation in either ear due to loss to follow-up or insufficient audiometric assessment. Permanent HL was identified in 11.3% (n = 9) of infants with OME and in 20.0% (n = 11) of those without OME. Infants with OME were significantly older at the time of HL confirmation (4.2 ± 2.1 months) and EI enrollment (5.4 ± 2.5 months) compared to those without OME at the time of HL confirmation (1.0 ± 1.0 months; p < .001) and EI enrollment (2.6 ± 1.8 months; p = .04).
Conclusion: Infants with failed NBHS and OME are highly susceptible to a significant delay in HL confirmation or lack of confirmatory hearing tests. Timely OME resolution with earlier ventilation tube insertion by 3 months of age and follow-up audiologic assessment is recommended.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/ohn.306 | DOI Listing |
Laryngoscope
June 2024
Michigan Ear Institute, Farmington Hills, Michigan, U.S.A.
Objectives: Evaluate the effect of rurality on newborn hearing screen outcomes in Michigan.
Methods: Patients in the Michigan Department of Health and Human Services (MDHHS) Newborn Hearing Screening database that failed or did not receive their initial screen from 2015 to 2020 were evaluated. Using the U.
Int J Neonatal Screen
July 2023
Sainte-Justine Research Center, Université de Montréal, Montreal, QC H3T 1C5, Canada.
Targeted screening for congenital CMV infection (cCMV), which entails CMV testing of infants who fail newborn hearing screening (NBHS), has become common practice. However, this strategy misses nearly all infected infants with normal hearing at birth who are nonetheless at high risk of subsequent hearing loss and would benefit from timely cCMV diagnosis. The objective of this study was to identify expanded criteria predictive of cCMV to increase the scope and utility of targeted newborn CMV screening.
View Article and Find Full Text PDFMicrobiol Spectr
June 2023
Assistance Publique - Hôpitaux de Paris, Hôpitaux Universitaires Paris Centre Site Cochin, Service de Bactériologie, Paris, France.
Clin Pediatr (Phila)
November 2023
Department of Otolaryngology, Head & Neck Surgery, LSU Health Shreveport, Shreveport, LA, USA.
This is a retrospective chart review of newborns referred to audiology between June and December 2020. Newborns who failed or did not have an initial newborn hearing screening (NBHS) at an academic, tertiary care medical center, either in the nursery or in the neonatal intensive care unit (NICU) prior to discharge, were referred for a follow-up audiology appointment. Forty-three patients were included who failed or did not receive an NBHS.
View Article and Find Full Text PDFOtolaryngol Head Neck Surg
September 2023
Division of Otolaryngology-Head and Neck Surgery, University of Utah School of Medicine, Salt Lake City, Utah, USA.
Objective: To identify outcomes in hearing loss (HL) diagnosis and intervention in infants with a failed newborn hearing screen (NBHS) and otitis media with effusion (OME) compared to those with failed NBHS and without OME.
Study Design: Retrospective review.
Setting: Tertiary medical center.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!